Form 4 Tracker
Jonathan Goldman

Director · 1 filing · Latest: Mar 28, 2026

Avalo Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AVTX
JONATHAN GOLDMANJun 2, 2026
Proposed Sale
$14.3942,833$616.2K
AVTX
Jonathan GoldmanDirectorMar 28, 2026
Option Exercise
3,1663,166